The First Experience of Ex-Vivo Lung Perfusion (EVLP) in Iran: An Effective Method to Increase Suitable Lung for Transplantation

BACKGROUND: Although lung transplantation is a well-accepted treatment for end-stage lung diseases patients, only 15%–20% of the brain-dead donors’ lungs are usable for transplantation. This results in high mortality of candidates on waiting lists. Ex-vivo lung perfusion (EVLP) is a novel method for...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafaghi, S., Najafizadeh, K., Sheikhy, K., Ansari Aval, Z., Farzanegan, B., Mafhoomi, Y., Faghih Abdollahi, Z., Emami, H., Mortaz, E., Porabdollah, M., Jahangiri Fard, A., Nikobayan Safaei, M., Slama, A., Aigner, C., Hosseini-Baharanchi, F. S., Abbasi Dezfuli, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Organ Transplantation Institute 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219583/
https://www.ncbi.nlm.nih.gov/pubmed/28078061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219583/
https://www.ncbi.nlm.nih.gov/pubmed/28078061

Ejemplares similares